Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

The price of first- and second-line ARVs to treat HIV are falling because of increased competition among generic producers, but newer ARVs continue to be priced astronomically high.

More >

The participants of the UN Summit on AIDS took a critical step by committing to reach 15 million people with HIV treatment by 2015, but they must take concrete action to truly make this happen.

More >

Now that research has shown that HIV treatment can reduce transmission by 96 percent, governments meeting at the UN Summit on AIDS must agree to put nine million people on treatment over the next four years.

More >

MSF and Oxfam warn that vaccination programs for the developing world are facing an acute funding crisis.

More >

Lagos/Berlin/New York, March 15, 2006 — People living with HIV/AIDS in developing countries can't get new and/or improved drugs that can make a critical difference, said the medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF). MSF also said that it refuses to accept the standard practice of drug companies to market less adapted drugs to African, Asian and Latin American countries while reserving improved or newly developed drugs for countries that can pay more. For this reason MSF is placing an order directly with the worldwide headquarters of Abbott Laboratories in Chicago for a new heat stable version of the drug called lopinavir/ritonavir, which the company right now only sells in the US at a price of US$9,687 (average wholesale price) per patient per year.

More >

Bangkok, January 11, 2006 — As talks take place in Chiang Mai, Thailand, this week on the intellectual property provisions of a proposed US-Thailand Free Trade Agreement, the international medical organization Doctors Without Borders/Médecins Sans Frontières (MSF) warns that acceptance of the US proposal could restrict access to essential medicines in Thailand and endanger the country's national HIV/AIDS treatment program.

More >

CAFTA Negotiations Roll Back US Promises to Put Public Health Before Profits

More >